570 556 captures · dernière capture : 3 mai 2026
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
386 223 captures · dernière capture : 14 avr. 2026
243 880 captures · dernière capture : 28 avr. 2026
Cannabis for medical purposes under the Cannabis Act: information and improvements On this page Access to cannabis for medical purposes For those accessing cannabis for medical purposes from a federally licensed seller For those registered with Health Canada to produce their own…
Counterfeit prescription drugs Learn about counterfeit prescription drugs, their risks to youth and how we try to prevent them. On this page About counterfeit prescription drugs Risks to youth Preventing counterfeit prescription drugs About counterfeit prescription drugs…
Get help with substance use On this page About Canada-wide services Provincial and territorial health and support services Programs for Indigenous peoples Substance use and chronic pain Mental health support About This page has resources and information for people who need help…
Canadian Student Alcohol and Drugs Survey Data on alcohol and drug use by youth in Canada. Explore trends in youth substance use over time, by province, and more with our interactive tool . Reports Summaries of results from previous survey cycles. 2023-2024 report 2021-2022…
Subsection 56(1) class exemption for practitioners, agents, pharmacists, persons in charge of a hospital, hospital employees, and licensed dealers to conduct activities with psilocybin and MDMA in relation to a special access program authorization This class exemption will be…
Application form for an exemption to use a controlled substance for scientific purposes To apply, you should be the Principal Investigator (PI) or person responsible for the project and should have a minimum of a bachelor’s degree in science (B.Sc.). If you are a practitioner,…
Controlled substance licence restrictions: Licences for controlled substances Licences Sale of controlled substances Advertising Compliance and enforcement Contact us This page is for holders of a controlled substances licence (dealer's licence). You should be familiar with the…
Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin January 11, 2022 Our file number: 21-121678-792 Health Canada is issuing this notice to…
Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications (PDF Version - 190 K) This guidance is being consulted on as part of the proposed clinical trial regulation modernization. To participate, please see Consultation: Modernizing the framework for clinical…
Good manufacturing practices guide for drug products (GUI-0001) Download the alternative format (PDF format, 2.4 MB, 159 pages) Organization: Health Canada Date published: July 2020 For industry information about good manufacturing practices and COVID-19, visit our Good…
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
